 Histamine Antagonists
"Histamine Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.
| Descriptor ID |
D006633
|
| MeSH Number(s) |
D27.505.519.625.375.425 D27.505.696.577.375.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Histamine Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Histamine Antagonists".
This graph shows the total number of publications written about "Histamine Antagonists" by people in this website by year, and whether "Histamine Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2007 | 2 | 0 | 2 | | 2013 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Histamine Antagonists" by people in Profiles.
-
Tocci EM, Robinson A, Belazarian L, Foley E, Wiss K, Silvestri DL. Excipients in Oral Antihistamines Can Perpetuate Allergic Contact Dermatitis. Pediatr Dermatol. 2015 Nov-Dec; 32(6):e242-4.
-
McEnery-Stonelake M, Silvestri DL. Contact allergens in oral antihistamines. Dermatitis. 2014 Mar-Apr; 25(2):83-8.
-
Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013 Apr 25; 368(17):1625-34.
-
Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin JS, Burban A, Arrang JM, Schwartz JC. Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol. 2007 Apr 15; 73(8):1215-24.
-
Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, Bozyczko-Coyne D, Spiegel K, Ohtsu H, Williams M, Lin JS. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol. 2007 Apr 15; 73(8):1157-71.
-
Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther. 2007 Jan; 320(1):365-75.
-
Holgate ST, Church MK, Howarth PH, Simons FE, Campbell A, Dunn N, Routledge P, Hindmarch I, Timmerman H, Camm J, Friedmann P, Canonica W, Scadding G, Devalia J, Renwick A. Antihistamines: back to the future. Summary of the conclusions. BSACI. British Society for Allergy and Clinical Immunology. Clin Exp Allergy. 1999 Jul; 29 Suppl 3:iv-vi.
-
Nompleggi DJ, Beinborn M, Roy A, Wolfe MM. The effect of recombinant cytokines on [14C]-aminopyrine accumulation by isolated canine parietal cells. J Pharmacol Exp Ther. 1994 Aug; 270(2):440-5.
-
Carraway RE, Cochrane DE, Salmonsen R, Muraki K, Boucher W. Neurotensin elevates hematocrit and plasma levels of the leukotrienes, LTB4, LTC4, LTD4 and LTE4, in anesthetized rats. Peptides. 1991 Sep-Oct; 12(5):1105-11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|